uniQure NV (QURE)
24.51
-14.60
(-37.33%)
USD |
NASDAQ |
Sep 29, 16:00
24.88
+0.37
(+1.51%)
Pre-Market: 08:38
uniQure Market Cap : 1.699B for Sept. 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 29, 2026 | 1.699B |
| September 28, 2026 | 2.712B |
| September 25, 2026 | 2.651B |
| September 24, 2026 | 2.657B |
| September 23, 2026 | 2.965B |
| September 22, 2026 | 3.139B |
| September 21, 2026 | 3.072B |
| September 18, 2026 | 3.051B |
| September 17, 2026 | 3.057B |
| September 16, 2026 | 2.946B |
| September 15, 2026 | 2.988B |
| September 14, 2026 | 3.115B |
| September 11, 2026 | 3.086B |
| September 10, 2026 | 3.083B |
| September 09, 2026 | 3.189B |
| September 08, 2026 | 3.167B |
| September 04, 2026 | 3.085B |
| September 03, 2026 | 3.110B |
| September 02, 2026 | 3.205B |
| September 01, 2026 | 3.318B |
| August 31, 2026 | 3.375B |
| August 28, 2026 | 3.378B |
| August 27, 2026 | 3.436B |
| August 26, 2026 | 3.533B |
| August 25, 2026 | 3.540B |
| Date | Value |
|---|---|
| August 24, 2026 | 3.291B |
| August 21, 2026 | 3.354B |
| August 20, 2026 | 3.390B |
| August 19, 2026 | 3.381B |
| August 18, 2026 | 3.285B |
| August 17, 2026 | 3.326B |
| August 14, 2026 | 3.371B |
| August 13, 2026 | 3.263B |
| August 12, 2026 | 3.129B |
| August 11, 2026 | 3.120B |
| August 10, 2026 | 3.194B |
| August 07, 2026 | 3.219B |
| August 06, 2026 | 3.145B |
| August 05, 2026 | 3.067B |
| August 04, 2026 | 3.029B |
| August 03, 2026 | 3.055B |
| July 31, 2026 | 3.025B |
| July 30, 2026 | 2.925B |
| July 29, 2026 | 2.778B |
| July 28, 2026 | 2.542B |
| July 27, 2026 | 2.649B |
| July 24, 2026 | 2.702B |
| July 23, 2026 | 2.485B |
| July 22, 2026 | 2.545B |
| July 21, 2026 | 2.527B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Kymera Therapeutics, Inc. | 9.149B |
| Sarepta Therapeutics, Inc. | 1.969B |
| Twist Bioscience Corp. | 11.67B |
| GRAIL, Inc. | 6.100B |
| Arrowhead Pharmaceuticals, Inc. | 9.350B |
Market Cap Related Metrics
| PS Ratio | 81.99 |
| PEG Ratio | -1.865 |
| Price to Book Value | 5.244 |
| Price | 24.51 |
| Earnings Yield | -16.52% |
| PEGY Ratio | -1.865 |